Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Debt Issued

Amneal Pharmaceuticals Inc Debt Issued Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Debt Issued from 2017 to 2018.
  • Amneal Pharmaceuticals Inc Debt Issued for the quarter ending December 12, 2018 was $-25m a 200.00% decrease of -50m year over year
  • Amneal Pharmaceuticals Inc Debt Issued for the last 12 months ending December 12, 2018 was $1,325m a 77.37% increase of 1,025m year over year
  • Amneal Pharmaceuticals Inc Annual Debt Issued for 2018 was $1,325m a 77.37% increase of 1,025m from 2017
  • Amneal Pharmaceuticals Inc Annual Debt Issued for 2017 was $300m a 25.00% increase of 75m from 2016
  • Amneal Pharmaceuticals Inc Annual Debt Issued for 2016 was $225m a -11.11% decrease of -25m from 2015
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Debt Issued Data

12/2018$-25m
09/2018$25m
06/2018$1,325m
12/2017$25m
06/2017$275m

Annual AMRX Debt Issued Data

2018$1,325m
2017$300m
2016$225m
2015$250m
2014$338m